China Shineway Pharmaceutical Group Limited Cash Flow Reinvestment Rate
China Shineway Pharmaceutical Group Limited cash flow reinvestment rate. China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Reinvestment Rate of 0.17x as of June 2023, reinvesting €26.64 Million (capex €24.57 Million plus investments €2.06 Million) from operating cash flow of €160.69 Million. Explore China Shineway Pharmaceutical Group Limi (C1S) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of China Shineway Pharmaceutical Group Limited (2013–2025)
Cash flow reinvestment rate of China Shineway Pharmaceutical Group Limited from 2013 to 2025. Historical reinvestment intensity for China Shineway Pharmaceutical Group Limited across 13 annual periods. Explore C1S capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
China Shineway Pharmaceutical Group Limited Cash Flow Reinvestment Rate by Year (2013–2025)
China Shineway Pharmaceutical Group Limited cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for China Shineway Pharmaceutical Group Limited. For the full cash flow conversion analysis, see cash flow conversion of China Shineway Pharmaceutical Group Limi.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | €348.24 Million | €1.17 Billion | €197.91 Million | ▼ -37.4% |
| 2024 | 0.48x | €457.50 Million | €963.13 Million | €140.11 Million | ▲ +186.1% |
| 2023 | 0.17x | €154.86 Million | €932.63 Million | €144.32 Million | ▲ +35.4% |
| 2022 | 0.12x | €136.13 Million | €1.11 Billion | €129.46 Million | ▼ -15.7% |
| 2021 | 0.15x | €102.37 Million | €703.15 Million | €93.63 Million | ▼ -15.4% |
| 2020 | 0.17x | €109.93 Million | €638.57 Million | €66.03 Million | ▼ -40.4% |
| 2019 | 0.29x | €106.33 Million | €368.00 Million | €88.40 Million | ▲ +13.1% |
| 2018 | 0.26x | €136.07 Million | €532.59 Million | €127.34 Million | ▲ +24.7% |
| 2017 | 0.20x | €100.56 Million | €490.65 Million | €91.83 Million | ▼ -19.4% |
| 2016 | 0.25x | €186.50 Million | €733.53 Million | €106.79 Million | ▲ +24.8% |
| 2015 | 0.20x | €151.71 Million | €744.71 Million | €106.56 Million | ▼ -12.1% |
| 2014 | 0.23x | €179.20 Million | €773.16 Million | €104.18 Million | ▼ -60.9% |
| 2013 | 0.59x | €308.46 Million | €519.89 Million | €261.89 Million | — |